Merck could lose up to $630 million in revenue after CDC changes HPV vaccine recommendation
MerckMerck(US:MRK) MarketWatch·2026-01-07 17:36

Merck could lose up to $630 million in Gardasil revenue this year now that the U.S. no longer recommends three doses of the HPV shot in the childhood vaccine schedule, according to Jefferies analysts. ...